Trademark Overview
On Tuesday, November 12, 2024, a trademark application was filed for EVOLUTION BIO with the United States Patent and Trademark Office. The USPTO has given the EVOLUTION BIO trademark a serial number of 98848881. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, November 12, 2024. This trademark is owned by Evolution Bio, Inc.. The EVOLUTION BIO trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Protein engineering services, namely, the recombination of genes customized to the specification of others to produce novel gene sequences for use in science, research, and medicine
Mixed biological preparations for the prevention and treatment of infectious diseases; therapeutic pharmaceuticals for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, as well as cancer and transplant rejections
Development of pharmaceutical preparations and medicines; research and development in the biotechnology field; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; research and development of pharmaceutical preparations and substances for use in clinical trials; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drugs, materials, and molecular development; software as a service (saas) services featuring computer software platforms for use in optimizing drugs, materials, and molecular discovery; platform as...
